Cargando…

The therapeutic potential of epigenetic manipulation during infectious diseases

Epigenetic modifications are increasingly recognized as playing an important role in the pathogenesis of infectious diseases. They represent a critical mechanism regulating transcriptional profiles in the immune system that contributes to the cell-type and stimulus specificity of the transcriptional...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, Joby, Morris, Paul, Dickman, Mark J., Dockrell, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109899/
https://www.ncbi.nlm.nih.gov/pubmed/27519803
http://dx.doi.org/10.1016/j.pharmthera.2016.07.013
_version_ 1782467632106045440
author Cole, Joby
Morris, Paul
Dickman, Mark J.
Dockrell, David H.
author_facet Cole, Joby
Morris, Paul
Dickman, Mark J.
Dockrell, David H.
author_sort Cole, Joby
collection PubMed
description Epigenetic modifications are increasingly recognized as playing an important role in the pathogenesis of infectious diseases. They represent a critical mechanism regulating transcriptional profiles in the immune system that contributes to the cell-type and stimulus specificity of the transcriptional response. Recent data highlight how epigenetic changes impact macrophage functional responses and polarization, influencing the innate immune system through macrophage tolerance and training. In this review we will explore how post-translational modifications of histone tails influence immune function to specific infectious diseases. We will describe how these may influence outcome, highlighting examples derived from responses to acute bacterial pathogens, models of sepsis, maintenance of viral latency and HIV infection. We will discuss how emerging classes of pharmacological agents, developed for use in oncology and other settings, have been applied to models of infectious diseases and their potential to modulate key aspects of the immune response to bacterial infection and HIV therapy.
format Online
Article
Text
id pubmed-5109899
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Pergamon Press
record_format MEDLINE/PubMed
spelling pubmed-51098992016-11-21 The therapeutic potential of epigenetic manipulation during infectious diseases Cole, Joby Morris, Paul Dickman, Mark J. Dockrell, David H. Pharmacol Ther Associate editor: A. Doseff Epigenetic modifications are increasingly recognized as playing an important role in the pathogenesis of infectious diseases. They represent a critical mechanism regulating transcriptional profiles in the immune system that contributes to the cell-type and stimulus specificity of the transcriptional response. Recent data highlight how epigenetic changes impact macrophage functional responses and polarization, influencing the innate immune system through macrophage tolerance and training. In this review we will explore how post-translational modifications of histone tails influence immune function to specific infectious diseases. We will describe how these may influence outcome, highlighting examples derived from responses to acute bacterial pathogens, models of sepsis, maintenance of viral latency and HIV infection. We will discuss how emerging classes of pharmacological agents, developed for use in oncology and other settings, have been applied to models of infectious diseases and their potential to modulate key aspects of the immune response to bacterial infection and HIV therapy. Pergamon Press 2016-11 /pmc/articles/PMC5109899/ /pubmed/27519803 http://dx.doi.org/10.1016/j.pharmthera.2016.07.013 Text en Crown Copyright © 2016 Published by Elsevier Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Associate editor: A. Doseff
Cole, Joby
Morris, Paul
Dickman, Mark J.
Dockrell, David H.
The therapeutic potential of epigenetic manipulation during infectious diseases
title The therapeutic potential of epigenetic manipulation during infectious diseases
title_full The therapeutic potential of epigenetic manipulation during infectious diseases
title_fullStr The therapeutic potential of epigenetic manipulation during infectious diseases
title_full_unstemmed The therapeutic potential of epigenetic manipulation during infectious diseases
title_short The therapeutic potential of epigenetic manipulation during infectious diseases
title_sort therapeutic potential of epigenetic manipulation during infectious diseases
topic Associate editor: A. Doseff
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109899/
https://www.ncbi.nlm.nih.gov/pubmed/27519803
http://dx.doi.org/10.1016/j.pharmthera.2016.07.013
work_keys_str_mv AT colejoby thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT morrispaul thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT dickmanmarkj thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT dockrelldavidh thetherapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT colejoby therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT morrispaul therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT dickmanmarkj therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases
AT dockrelldavidh therapeuticpotentialofepigeneticmanipulationduringinfectiousdiseases